MyPharmacy+

Create-OD Tablet

Manufactured By Edifice Life Sciences Pvt Ltd

Salt Synonyms

Rs. 427.50

MRP 450.00

(5% OFF)

Includes all taxes

Package SIZE

strip of 10 tablets

Price may vary depending on the product batch*

100% Authentic
Products

Free
Shipping*

Products
Return Policy

Information about Create-OD Tablet

Uses / Indications:

As mentioned on the label|Or as advised by your healthcare practitioner|

Introduction:

Create-OD Tablet is recommended for general sluggishness weakness lethargy exhaustion irritability low immunity and convalescence and as a supplement for chronic illnesses. All of these elements work together to improve the health state and have a concentrated action.

How to use:

This formulation is indicated in general debility weakness lethargy and fatigue|It enhances the immunity of the body|It may be used in cases of chronic illness|Calcium helps to promote bone health|It nourishes the body for its proper development and growth|

Description:

Promotes a healthy body|Boosts the immunity|Aids in the proper development of the body|Aids in the strengthening of the bones and joints

Benefits:

Safety Advise:

Read the label carefully before use|Store in a cool and dry place away from sunlight|Keep out of reach of children|</div

Create-OD Tablet

Manufactured By Edifice Life Sciences Pvt Ltd

Salt Synonyms

Rs. 427.50

MRP 450.00

Includes all taxes

Package SIZE

Available Substitutes

1-CC Oral Suspension Sugar Free

Azure Pharmaceuticals

1 Tree Co Q 10 Veg Capsule

Saisir Global Technologies Pvt Ltd

1 Tree Omega 3 6 9 Veg Capsule

Saisir Global Technologies Pvt Ltd

1 Tree Sleep Tight Oral Spray Strawberry

Saisir Global Technologies Pvt Ltd

10 AM Vegetable Capsule

Kachhela Medex Pvt Ltd

Uses / Indications:

Introduction:

How to use:

Description:

Benefits:

Safety Advise:

If you miss a dose:

Fact Box:

Primary Use:

Common Side Effects:

Alcohol Interaction:

Pregnancy Interaction:

Lactation Interaction:

Driving Interaction:

Kidney Interaction:

Liver Interaction:

Q&A: